Suppr超能文献

双萘二甲酰亚胺3:N,N'-双[2-(1,8-萘二甲酰亚胺基)-乙基]链烷二胺的合成与抗肿瘤活性

Bis-naphthalimides 3: synthesis and antitumor activity of N,N'-bis[2-(1,8-naphthalimido)-ethyl] alkanediamines.

作者信息

Braña M F, Castellano J M, Morán M, Pérez de Vega M J, Perron D, Conlon D, Bousquet P F, Romerdahl C A, Robinson S P

机构信息

Universidad San Pablo-CEU, Departamento de Química Orgánica y Farmacéutica, Madrid, Spain.

出版信息

Anticancer Drug Des. 1996 Jun;11(4):297-309.

PMID:8679053
Abstract

The bis-naphthalimides are a new class of antitumor agent. Previously, we have described initial synthetic series which established that two naphthalimide chromophores joined by polyamine linkers can produce agents with antitumor activity. We now extend these studies to describe the synthesis of a N,N'-bis[1,8-naphthalimido)-ethyl]alkanediamine series and examine the alkyl linker and chromophore substitution requirements for optimal antitumor activity. As a result, a bis-naphthal-imidoethyl derivative with no chromophore substitution and a NH-(CH2)3-NH bridge was identified. This agent (LU 79553) had both potent cellular cytotoxicity (IC50 = 0.014 microM) and was curative against MX-1 tumors grown in athymic mice. It has now been selected for clinical development.

摘要

双萘二甲酰亚胺是一类新型抗肿瘤药物。此前,我们已经描述了初步的合成系列,该系列证实通过多胺连接子连接的两个萘二甲酰亚胺发色团可产生具有抗肿瘤活性的药物。我们现在扩展这些研究,以描述N,N'-双[1,8-萘二甲酰亚胺基)-乙基]链烷二胺系列的合成,并研究烷基连接子和发色团取代对最佳抗肿瘤活性的要求。结果,鉴定出一种没有发色团取代且具有NH-(CH2)3-NH桥的双萘二甲酰亚胺乙基衍生物。该药物(LU 79553)具有强大的细胞毒性(IC50 = 0.014微摩尔),并且对无胸腺小鼠体内生长的MX-1肿瘤具有治愈作用。它现已被选入临床开发阶段。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验